DSIP in the treatment of withdrawal syndromes from alcohol and opiates
Native rhIGF-1 (mecasermin, brand name Increlex) is FDA-approved only for the long-term treatment of growth failure in pediatric patients with severe primary IGF-1 deficiency or with GH gene deletion who have developed neutralizing antibodies to GH
Yes Telos Rx prescribes compounded PT-141 through an online medical visit, from about $99/month
Further, it stimulates fibroblasts and increases nitric oxide production, aiding in tissue regeneration [3, 9]
Stacking DSIP with Other Compounds Some users combine DSIP with other compounds to enhance sleep quality or address multiple aspects of recovery
These growth factors support the formation of new blood vessels, increase cell turnover, and encourage follicles to re-enter the growth phase, explains Dr